Here are four key notes:
1. Cell microencapsulation technology allows for the positioning of cells in a semi-permeable membrane and provides for a bidirectional diffusion of molecules essential for cell metabolism.
2. The semi-permeable nature of the membrane aims to prevent immune cells and antibodies from destroying the encapsulated cells.
3. BioRestorative’s ThermoStem Program uses brown adipose-derived stem cells as a platform for the development of cell-based therapy targeting metabolic disorders such as obesity and type 2 diabetes.
4. The company is working on the development of its brown adipose cell therapy program by evaluating certain cell delivery encapsulation technology that would enable transplanted brown adipose cells to effectively maintain or regulate normal metabolism in humans.
More articles on ASC issues:
Physicians file CON for new surgery center in Vermont: 4 things to know
5 things to know about Tenet’s cash flow
Flipping HOPDs to ASCs: A new industry trend? 5 key thoughts from ASCOA CEO Luke Lambert
